FR2730495B1 - Derive de proinsuline et procede pour la production d'insuline humaine - Google Patents

Derive de proinsuline et procede pour la production d'insuline humaine

Info

Publication number
FR2730495B1
FR2730495B1 FR9601888A FR9601888A FR2730495B1 FR 2730495 B1 FR2730495 B1 FR 2730495B1 FR 9601888 A FR9601888 A FR 9601888A FR 9601888 A FR9601888 A FR 9601888A FR 2730495 B1 FR2730495 B1 FR 2730495B1
Authority
FR
France
Prior art keywords
production
human insulin
proinsulin derivative
proinsulin
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9601888A
Other languages
English (en)
Other versions
FR2730495A1 (fr
Inventor
Hang Cheol Shin
Seung Gu Chang
Dae Young Kim
Chong Suhl Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanil Synthetic Fiber Co Ltd
Original Assignee
Hanil Synthetic Fiber Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanil Synthetic Fiber Co Ltd filed Critical Hanil Synthetic Fiber Co Ltd
Publication of FR2730495A1 publication Critical patent/FR2730495A1/fr
Application granted granted Critical
Publication of FR2730495B1 publication Critical patent/FR2730495B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9601888A 1995-02-15 1996-02-15 Derive de proinsuline et procede pour la production d'insuline humaine Expired - Fee Related FR2730495B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950002751A KR0150565B1 (ko) 1995-02-15 1995-02-15 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법

Publications (2)

Publication Number Publication Date
FR2730495A1 FR2730495A1 (fr) 1996-08-14
FR2730495B1 true FR2730495B1 (fr) 2001-11-23

Family

ID=19408146

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9601888A Expired - Fee Related FR2730495B1 (fr) 1995-02-15 1996-02-15 Derive de proinsuline et procede pour la production d'insuline humaine

Country Status (6)

Country Link
US (1) US5962267A (fr)
JP (1) JPH08333395A (fr)
KR (1) KR0150565B1 (fr)
DE (1) DE19605657B4 (fr)
FR (1) FR2730495B1 (fr)
GB (1) GB2298206B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0741188A3 (fr) * 1995-05-05 1999-07-14 Eli Lilly And Company Insuline monocaténaire avec bioactivité élevée
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US7169889B1 (en) * 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
ATE474930T1 (de) 1999-12-29 2010-08-15 Novo Nordisk As Verfahren zur herstellung von insulinvorläufern und analogen von insulinvorläufern mit verbesserter fermentationsausbeute in hefe
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
US6777207B2 (en) * 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
JP4773023B2 (ja) * 1999-12-29 2011-09-14 ノボ ノルディスク アクティーゼルスカブ インスリン前駆体及びインスリン前駆体類似体の製造方法
US7378390B2 (en) * 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
ATE270306T1 (de) * 2000-10-02 2004-07-15 Univ Yonsei Seoul Einkettige insulinanaloge
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
WO2002079251A2 (fr) * 2001-04-02 2002-10-10 Novo Nordisk A/S Methode de fabrication de precurseurs d'insuline humaine
US7105314B2 (en) * 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
ATE443082T1 (de) * 2001-04-02 2009-10-15 Novo Nordisk As Insulinvorstufen und verfahren zu deren herstellung
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
MXPA03011013A (es) * 2001-06-08 2004-02-27 Boehringer Ingelheim Pharma Constructos de acidos nucleicos utiles para la produccion regulada por glucosa de insulina humana en lineas de celulas somaticas.
US20030040601A1 (en) * 2001-06-08 2003-02-27 Ivan Diers Method for making insulin precursors and insulin analog precursors
EP2626368B1 (fr) 2004-07-19 2016-12-21 Biocon Limited Conjugués insuline-oligomère, formulations et utilisations de ceux-ci
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
PT2074141T (pt) 2006-09-22 2016-11-10 Novo Nordisk As Análogos de insulina resistentes a proteases
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
US7790677B2 (en) * 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
ES2632504T3 (es) 2007-11-20 2017-09-13 Ambrx, Inc. Polipéptidos de insulina modificados y sus usos
CN102470165B (zh) 2009-06-26 2014-12-24 诺沃-诺迪斯克有限公司 包含胰岛素、烟酰胺和氨基酸的制剂
WO2012115641A1 (fr) 2011-02-23 2012-08-30 Elona Biotechnologies Compositions de pro-insuline lis-pro et procédés de production d'analogues d'insuline lis-pro à partir de celles-ci
WO2012115640A1 (fr) 2011-02-23 2012-08-30 Elona Biotechnologies Compositions liquides contenant de l'insuline et leurs procédés de fabrication
WO2012115637A1 (fr) 2011-02-23 2012-08-30 Elona Biotechnologies Compositions de pro-insuline aspart et procédés de production d'analogues de l'insuline aspart
WO2012115638A1 (fr) 2011-02-23 2012-08-30 Elona Biotechnologies Compositions de pro-insuline glargine et procédés de production d'analogues de l'insuline glargine à partir de celles-ci
WO2013059213A1 (fr) 2011-10-18 2013-04-25 Amidebio, Llc Analogues d'insuline chimiquement et thermodynamiquement stables et leurs procédés de production améliorés
WO2013186138A1 (fr) 2012-06-14 2013-12-19 Novo Nordisk A/S Préparation comprenant de l'insuline, du nicotinamide et de l'arginine
WO2014172488A2 (fr) 2013-04-17 2014-10-23 AmideBio LLC Analogues d'insuline chimiquement et thermodynamiquement stables et leurs procédés de production améliorés
CN104592381A (zh) * 2013-10-31 2015-05-06 江苏万邦生化医药股份有限公司 一种利拉鲁肽中间体多肽的制备方法
JP2018531007A (ja) * 2015-09-24 2018-10-25 ハンミ ファーマシューティカル カンパニー リミテッド インスリンの製造方法
KR20220121833A (ko) 2019-12-30 2022-09-01 간 앤 리 파마슈티칼스 컴퍼니, 리미티드 인슐린 유도체
BR112022013042A2 (pt) 2019-12-30 2022-10-18 Gan & Lee Pharmaceuticals Co Ltd Composto da fórmula b, formulação farmacêutica, composição farmacêutica, método para tratar ou prevenir hiperglicemia, diabetes e/ou obesidade

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
CA1204682A (fr) * 1981-06-19 1986-05-20 Saran A. Narang Adapteurs, synthese et clonage des genes proinsuliniques
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US5013653A (en) * 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
DK336188D0 (da) * 1988-06-20 1988-06-20 Nordisk Gentofte Propeptider
DE3919852A1 (de) * 1988-06-23 1989-12-28 Hoechst Ag Mini-proinsulin, seine herstellung und verwendung
US5304473A (en) * 1991-06-11 1994-04-19 Eli Lilly And Company A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
EP0707650B1 (fr) * 1993-06-21 2003-05-21 Genentech, Inc. Procede de production de relaxine humaine
WO1995016708A1 (fr) * 1993-12-17 1995-06-22 Novo Nordisk A/S Composes du type pro-insuline

Also Published As

Publication number Publication date
DE19605657A1 (de) 1996-08-22
DE19605657B4 (de) 2005-12-22
US5962267A (en) 1999-10-05
KR960031602A (ko) 1996-09-17
JPH08333395A (ja) 1996-12-17
GB2298206B (en) 1998-12-09
GB9602998D0 (en) 1996-04-10
GB2298206A (en) 1996-08-28
KR0150565B1 (ko) 1998-08-17
FR2730495A1 (fr) 1996-08-14

Similar Documents

Publication Publication Date Title
FR2730495B1 (fr) Derive de proinsuline et procede pour la production d'insuline humaine
FR2634194B1 (fr) Procede de production d'alumines boehmitiques
FR2624052B1 (fr) Procede et appareil de reglage de la course d'une presse
MA22668A1 (fr) Procede de preparation d'oxamides .
MA22481A1 (fr) Procede de preparation d'acides imidazolyl - alcenoiques .
HUP9802259A3 (en) 1,4,5-substituted imidazole compounds, pharmaceutical compounds containing them, process for producing them and their use
FR2642039B1 (fr) Procede et dispositif d'alimentation en continu de flans
FR2722189B1 (fr) Nouveau procede de preparation d'un composite hydraulique
FR2669465B1 (fr) Source d'electrons et procede de realisation.
FR2736353B1 (fr) Procede de preparation d'alcools de guerbet
FR2741638B1 (fr) Procede et installation de preparation en continu d'une pate de cellulose
FR2662178B1 (fr) Procede de preparation d'intermediaires utiles dans la synthese de benzothiazepines.
FR2775919B1 (fr) Procede de traitement "mecano-chimique" d'un materiau
MA24534A1 (fr) Procede pour la production d'irones
FR2666334B1 (fr) Procede continu de preparation d'acrylamides et de methacrylamides n-substitues.
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
FR2739373B1 (fr) Procede de preparation de catalyseurs d'ammoxydation
FR2760823B1 (fr) Procede et installation de production d'air de qualite medicale
FR2644161B1 (fr) Procede de preparation d'amides n-arylsubstitues
FR2677354B1 (fr) Procede pour la preparation d'esters d'acides racemisables.
FR2737664B1 (fr) Procede pour la production d'un dispositif implantable hemocompatible, et dispositif implantable ainsi produit
FR2743072B1 (fr) Procede de preparation d'acides perfluoroalcanecarboxyliques et perfluoroalcanesulfoniques
FR2772755B1 (fr) Procede continu de preparation de chlorure de pivaloyle et de chlorure d'aroyle
FR2729387B1 (fr) Procede pour la fabrication d'hydroxy-alcoxy-benzophenones
AU8020791A (en) Method and product for the treatment of gastric disease

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081031